{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:32:11Z","timestamp":1791297131787,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.09.098","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T09:35:07Z","timestamp":1254735307000},"page":"632-649","source":"Crossref","is-referenced-by-count":252,"title":["Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses"],"prefix":"10.1016","volume":"28","author":[{"given":"Bruno","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Guirakhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Barban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.098_bib1","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"issue":"9599","key":"10.1016\/j.vaccine.2009.09.098_bib2","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/vbz.2007.0137","article-title":"Neuroinvasive disease incidence in the United States, 2002\u20132006","volume":"8","author":"Lindsey","year":"2008","journal-title":"Vector-Borne Zoonotic Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/vbz.2007.0109","article-title":"Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002\u20132004","volume":"8","author":"Murray","year":"2008","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb02680.x","article-title":"Prospects for development of a vaccine against the West Nile virus","volume":"951","author":"Monath","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2009.09.098_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"van den Hurk","year":"2009","journal-title":"Annu Rev Entomol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.098_bib7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3201\/eid1411.071368","article-title":"Domestic pigs and Japanese encephalitis virus infection, Australia","volume":"14","author":"van-den-Hurk","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib8","series-title":"Vaccines","first-page":"311","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.098_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-59403-8_6","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Curr Topics Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cells cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.098_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.09.098_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cimid.2007.07.011","article-title":"Towards a dengue vaccine: progress to date and remaining challenges","volume":"31","author":"Guy","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2009.09.098_bib14","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","article-title":"Current use and development of vaccines for Japanese encephalitis","volume":"8","author":"Beasley","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2009.09.098_bib16","series-title":"NIAID, NIH, vol. 1, Frontiers in Research","first-page":"459","article-title":"Research and development of chimeric flavivirus vaccines","author":"Delagrave","year":"2008"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib17","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.098_bib19","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2009.09.098_bib20","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib21","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.09.098_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(01)00273-8","article-title":"Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses","volume":"79","author":"Caufour","year":"2001","journal-title":"Virus Res"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.09.098_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/S0074-02762000000700037","article-title":"The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines","volume":"95","author":"Bonaldo","year":"2000","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2009.09.098_bib24","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JVI.77.6.3655-3668.2003","article-title":"Yellow fever virus\/dengue-2 virus and yellow fever virus\/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model","volume":"77","author":"Chambers","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib25","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1128\/JVI.74.17.8094-8101.2000","article-title":"Chimeric yellow fever\/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response","volume":"74","author":"van der Most","year":"2000","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.098_bib26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1590\/S0100-879X2005001200012","article-title":"Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys","volume":"38","author":"Galler","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2009.09.098_bib27","unstructured":"Guy B, Guirakhoo F, Watson M, Higgs S, Monath TP. Safety of flavivirus chimeric vaccines: answer to Ishikawa et al. [Vaccine 26 (22) (2008) 2772\u20132781]. Vaccine 2008;26:4107\u20138."},{"key":"10.1016\/j.vaccine.2009.09.098_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","volume":"401","author":"Lehrman","year":"1999","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.vaccine.2009.09.098_bib29","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines","volume":"151","author":"Mantel","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2009.09.098_bib31","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structure of immature flavivirus particles","volume":"11","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2009.09.098_bib33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4269\/ajtmh.1984.33.672","article-title":"Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells","volume":"4","author":"Halstead","year":"1984","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.098_bib34","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1099\/vir.0.82455-0","article-title":"Substitution or deletion mutations between nt 54 and 70 in the 5\u2019 non-coding region of dengue type 2 virus produce variable effects on virus viability","volume":"88","author":"Sirigulpanit","year":"2007","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.098_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib36","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib37","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"8","author":"Guirakhoo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib38","first-page":"227","article-title":"Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice","volume":"32","author":"Miller","year":"1988","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib39","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/JVI.76.12.6172-6184.2002","article-title":"Neuroblastma cell-adapted yellow fever 17D virus: characterization of a viral variant associated with persistent infection and decreased virus spread","volume":"76","author":"Vlaycheva","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2009.09.098_bib41","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.098_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.qco.0000244047.31135.fa","article-title":"Immunopathological mechanisms in dengue and dengue hemorrhagic fever","volume":"19","author":"Green","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib43","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JVI.75.8.3501-3508.2001","article-title":"Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis","volume":"75","author":"Libraty","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib44","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/JVI.79.4.2432-2439.2005","article-title":"Differential effects of dengue virus on infected and bystander dendritic cells","volume":"79","author":"Palmer","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4269\/ajtmh.2005.72.74","article-title":"Replication of chimeric yellow fever virus-dengue serotype 1\u20134 virus vaccine strains in dendritic and hepatic cells","volume":"72","author":"Brandler","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4269\/ajtmh.2007.76.144","article-title":"Innate immune responses in human dendritic cells upon infection by chimeric yellow fever dengue vaccines serotype 1 to 4","volume":"76","author":"Deauvieau","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.098_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2009.09.098_bib48","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2009.09.098_bib49","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1016\/j.vaccine.2007.09.026","article-title":"Analysis of ChimeriVax Japanese encephalitis virus envelope for T-cell epitopes and comparison to circulating strain sequences","volume":"25","author":"De Groot","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib50","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1128\/JVI.02273-08","article-title":"Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus","volume":"83","author":"Lobigs","year":"2009","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.098_bib51","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.010420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib53","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib54","unstructured":"WHO Technical report series, N\u00b0 872; 1998."},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2009.09.098_bib55","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib56","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AEM.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vaccin"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.098_bib60","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/382280","article-title":"Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand","volume":"189","author":"Endy","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib62","unstructured":"Morrison D, Capeding MR, Poo JL, Forrat R, Dumas R, Lang J. Safety and infectivity of tetravalent chimeric live attenuated dengue vaccine in different age populations in endemic and non-endemic areas. ASTMH 56th meeting 2007, Abstract # 344."},{"key":"10.1016\/j.vaccine.2009.09.098_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib65","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.09.098_bib66","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.098_bib67","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/340822","article-title":"Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren","volume":"185","author":"Mangada","year":"2002","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib68","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.175.4.2676","article-title":"Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes","volume":"175","author":"Mangada","year":"2005","journal-title":"J Immunol"},{"issue":"45","key":"10.1016\/j.vaccine.2009.09.098_bib69","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib70","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.09.098_bib71","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.098_bib72","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2009.09.098_bib73","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines. WHO, Geneva. 2\u20133 September 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"34\/35","key":"10.1016\/j.vaccine.2009.09.098_bib74","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/0022-1317-77-4-705","article-title":"Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells","volume":"77","author":"Murali-Krishna","year":"1996","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1348-0421.1995.tb02200.x","article-title":"Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus","volume":"39","author":"Desai","year":"1995","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1099\/vir.0.19531-0","volume":"85","author":"Kumar","year":"2004","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib78","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2000.62.480","article-title":"Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF\/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes","volume":"62","author":"Bhatt","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.098_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2915.2003.00438.x","article-title":"Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes","volume":"17","author":"Johnson","year":"2003","journal-title":"Med Vet Entomol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.098_bib80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.2002.67.260","article-title":"Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes","volume":"67","author":"Johnson","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2004.70.89","article-title":"Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction","volume":"70","author":"Johnson","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib82","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4269\/ajtmh.2006.75.986","article-title":"Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand","volume":"75","author":"Higgs","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/527328","article-title":"Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax\u2013Dengue 4 does not enhance infection of Aedes aegypti mosquitoes","volume":"197","author":"McGee","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib84","first-page":"182","article-title":"Transmission de la fi\u00e8vre jaune par un moustique palearetique r\u00e9pandu dans la r\u00e9gion parisienne, l\u2019 Aedes geniculatus Oliv","volume":"205","author":"Roubaud","year":"1937","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.vaccine.2009.09.098_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1084\/jem.66.2.133","article-title":"Multiplication of the virus of yellow fever in Aedes aegypti","volume":"66","author":"Whitman","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.09.098_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4269\/ajtmh.1939.s1-19.19","article-title":"Failure of Aedes aegypti to transmit yellow fever cultured virus (17D)","volume":"19","author":"Whitman","year":"1939","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib87","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"Jennings","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib88","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1099\/vir.0.82023-0","article-title":"Role of the Yellow Fever Virus Structural Protein Genes in Viral Dissemination from the Aedes aegypti Mosquito Midgut","volume":"87","author":"McElroy","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib89","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4269\/ajtmh.2006.75.1158","article-title":"Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3\u2032non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut","volume":"75","author":"McElroy","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/vbz.2007.0269","article-title":"Characterization of the antigen distribution and tissue tropisms of three phenotypically distinct yellow fever virus variants in orally infected Aedes aegypti mosquitoes","volume":"8","author":"McElroy","year":"2008","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib91","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.56.6.853","article-title":"Transmission of neurotropic yellow fever virus by Stegomyia mosquitoes","volume":"56","author":"Davis","year":"1932","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.09.098_bib92","first-page":"305","article-title":"Recherches sur la transmission par la voie stegomyienne du virus neurotrope murin de la fi\u00e8vre jaune","volume":"26","author":"Roubaud","year":"1933","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.vaccine.2009.09.098_bib93","first-page":"172","article-title":"La transmission par piqure de Stegomyia, du virus amaril neurotrope pr\u00e9sent dans le sang des personnes r\u00e9cemment vaccin\u00e9es, est-elle possible dans les r\u00e9gions ou ce moustique existe en abondance?","volume":"5","author":"Peltier","year":"1939","journal-title":"Rev d\u2019Immunol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib94","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4269\/ajtmh.1977.26.985","article-title":"Aedes aegypti strain fitness for yellow fever virus transmission","volume":"26","author":"Aitken","year":"1977","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib95","first-page":"232","article-title":"In vitro transmission of yellow fever virus by geographic strains of Aedes aegypti","volume":"39","author":"Beaty","year":"1979","journal-title":"Mosquito News"},{"key":"10.1016\/j.vaccine.2009.09.098_bib96","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4269\/ajtmh.1985.34.1219","article-title":"Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations","volume":"34","author":"Tabachnick","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.098_bib97","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1099\/vir.0.80746-0","article-title":"Characterization of yellow fever virus-mosquito interactions using an infectious clone of the wild-type Asibi virus","volume":"86","author":"McElroy","year":"2005","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.098_bib98","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2006.75.659","article-title":"Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever\/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE)","volume":"75","author":"Reid","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4269\/ajtmh.2003.69.78","article-title":"Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus Ossifragus)","volume":"69","author":"Langevin","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.098_bib100","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"dos Santos","year":"1995","journal-title":"Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.098_bib102","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9426","key":"10.1016\/j.vaccine.2009.09.098_bib103","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib104","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/590915","article-title":"Safety concerns with regard to live attenuated flavivirus vaccines","volume":"198","author":"Seligman","year":"2008","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2009.09.098_bib105","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.vaccine.2004.11.069","article-title":"Recombination and flavivirus vaccines: a commentary","volume":"23","author":"Monath","year":"2005","journal-title":"Vaccine"},{"issue":"9433","key":"10.1016\/j.vaccine.2009.09.098_bib106","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(04)16800-1","article-title":"Arguments for live flavivirus vaccines","volume":"364","author":"Hombach","year":"2004","journal-title":"Lancet"},{"issue":"37\u201338","key":"10.1016\/j.vaccine.2009.09.098_bib107","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1016\/j.vaccine.2007.07.016","article-title":"Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE)","volume":"25","author":"Pugachev","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib108","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/527329","article-title":"Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates","volume":"197","author":"McGee","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib109","unstructured":"Lefeuvre A. Caract\u00e9risation des interactions entre les cellules h\u00e9patiques et les souches sauvage et vaccinale du virus de la fi\u00e8vre jaune: application \u00e0 l\u2019\u00e9tude de virus fi\u00e8vre jaune chim\u00e9riques utilis\u00e9s pour le d\u00e9veloppement d\u2019un vaccin contre la dengue. Dipl\u00f4me de Doctorat 2005; Universit\u00e9 Claude Bernard Lyon 1, N\u00b0 129-2005."},{"issue":"48","key":"10.1016\/j.vaccine.2009.09.098_bib110","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.098_bib111","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/j.vaccine.2008.05.058","article-title":"Guidelines for the clinical evaluation of dengue vaccines in endemic areas. Summary of a WHO technical consultation","volume":"26","author":"Edelman","year":"2008","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2009.09.098_bib112","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1016\/j.vaccine.2004.03.042","article-title":"Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine","volume":"22","author":"Guy","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.098_bib113","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/431520","article-title":"Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection","volume":"192","author":"Laoprasopwattana","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4269\/ajtmh.2006.75.1.0750026","article-title":"Short report: immune response and occurrence of dengue infection in Thai children three to eight years after vaccination with live attenuated tetravalent dengue vaccine","volume":"75","author":"Chanthavanich","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.098_bib115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.098_bib116","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/528805","article-title":"Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response","volume":"197","author":"Guilarde","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.098_bib117","unstructured":"Sun W. Meeting of the WHO Task Force on Clinical Trials of Dengue Vaccines. Bangkok, Thailand; October 2004."},{"key":"10.1016\/j.vaccine.2009.09.098_bib118","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2008.08.008","article-title":"Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model","volume":"380","author":"Kyle","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.098_bib119","unstructured":"Guy B, Barban V, Lang J. Preclinical research and evaluation of dengue vaccine candidates. PDVI; in press."},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/S0100-879X1997000200002","article-title":"The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector","volume":"30","author":"Galler","year":"1997","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.098_bib121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(98)00036-7","article-title":"Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations","volume":"55","author":"Xie","year":"1998","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.098_bib122","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/vir.0.18660-0","article-title":"The extent of homologous recombination in members of the genus Flavivirus","volume":"84","author":"Twiddy","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.098_bib123","unstructured":"Barban V, Girerd Y, Mantel M, Aguirre M, Petiard F, Colombani S, et al. Replication and temperature-sensitivity profiles on Vero, Huh-7 and HepG2 cells, of different wild-type compared to either Dengue virus attenuated strains, or chimeric YF viruses presenting Dengue envelope. Abstract #458. 55th ASTMH meeting Atlanta; 2006."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T15:51:46Z","timestamp":1590162706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09014455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09014455"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}